STIM (Neuronetics, Inc. Common Stock) Stock Analysis - Insider Trades
Neuronetics, Inc. Common Stock (STIM) is a publicly traded Healthcare sector company. As of May 21, 2026, STIM trades at $1.20 with a market cap of $82.11M and a P/E ratio of -0.85. STIM moved +0.00% today. Year to date, STIM is -15.60%; over the trailing twelve months it is -72.26%. Its 52-week range spans $0.52 to $5.92. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces STIM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Does Rallies show Form 4 insider transactions for STIM?
Yes. Rallies tracks STIM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is STIM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STIM. It does not provide personalized investment advice.